ФАКТОРЫ РИСКА РАЗВИТИЯ ДИАРЕИ, АССОЦИИРОВАННОЙ С ŒOSTRIDIUM DIFFICILE, У КОЛОПРОКТОЛОГИЧЕСКИХ БОЛЬНЫХ (обзор литературы)

клостридиальный колит, псевдомембранозный колит, антибиотико-ассоциированная диарея

1. Пилиев Д.В., Ачкасов С.И., Корнева Т.К. и соавт. Антибиотикоассоциированная диарея: современное состояние проблемы. Российский Журнал Гастроэнтерологии, Гепатологии, Колопроктологии. - 2014. - № 5. - с. 54-61.

2. Пикунов Д.Ю., Рыбаков Е.Г. и соавт. Псевдомембранозный колит (обзор литературы). Колопроктология. - 2010. - №2 (32). - с. 55-60.

3. Шелыгин Ю.А., Головенко О.В., Головенко А.О. и соавт. Трансплантация фекальной микробиоты - перспективы применения при заболеваниях кишечника (обзор литературы). Колопроктология. - 2015. - №4 (54). - с. 65-73.

4. Abdelsattar Z.M. et al. Postoperative Burden of Hospital-Acquired Clostridium difficile Infection. Infection Control & Hospital Epidemiology. - 2015. -№1 (36). - p. 40-46.

5. Abou Chakrap N. et al. Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. - 2015. - №12 (61). -p. 1781-8.

6. Ahmetagic S. et al. Clostridium difficile infection in hospitalized patients at university clinical center tuzla, bosnia and herzegovina: a 4 year experience. Materia socio-medica. - 2013. - №3 (25). - p. 153-7.

7. Alicinop et al. Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population. Epidemiology and infection. - 2016. - №12 (144). - p. 2517-26.

8. Angarone M., Ison M.G. Diarrhea in solid organ transplant recipients. Current opinion in infectious diseases. - 2015. - №4 (28). - p. 308-16.

9. Aquinap.T. et al. High Variability in Nosocomial Clostridium difficile Infection Rates Across Hospitals After Colorectal Resection. Diseases of the Colon & Rectum. - 2016. - №4 (59). - p. 323-331.

10. Bartlett J.G. Historical perspectives on studies of Clostridium difficile andp. difficile infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. - 2008. -Supplement 1 (46 Suppl 1). - p. S4-11.

11. Bartlett J.G., Onderdonk A.B., Cisneros R.L. Clindamycin-associated colitis in hamsters: protection with vancomycin. Gastroenterology. - 1977. - № 4 Pt 1 (73). - p. 772-6.

12. Buonomo E.L., Petri W.A. The microbiota and immune response during Clostridium difficile infection. Anaerobe. - 2016. (41). - p. 79-84.

13. Clements A.C. et al. Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. The Lancet Infectious Diseases. - 2010. -№6 (10). - p. 395-404.

14. Cohen S.H. et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infection Control and Hospital Epidemiology. -2010. - №5 (31). - p. 431-455.

15. Dave M. et al. Opportunistic Infections Due to Inflammatory Bowel Disease Therapy. Inflammatory Bowel Diseases. - 2014. - №1 (20). - p. 196-212.

16. Deshpande A. et al. Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis. Infection control and hospital epidemiology. - 2015. - №4 (36). - p. 452-60.

17. Eichel-Streiberp et al. Morphological changes in adherent cells induced by Clostridium difficile toxins. Biochemical Society transactions. - 1991. - №4 (19). -p. 1154-60.

18. Eliakim-Raz N. et al. Predicting Clostridium difficile infection in diabetic patients and the effect of metformin therapy: a retrospective, case-control study. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology. - 2015. -№6 (34). - p. 1201-5.

19. Goudarzi M. et al. Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options. Scientifica. - 2014. (2014). p. 916826.

20. Guo S. et al. The recombinant Lactococcus lactis oral vaccine induces protection againstp. difficile spore challenge in a mouse model. Vaccine. - 2015. -№13 (33). - p. 1586-1595.

21. Hainesp F. et al. Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes. AIDS (London, England). - 2013. -№17 (27). - p. 2799-807.

22. Hashash J.G., Binion D.G. Managing Clostridium difficile in inflammatory bowel disease (IBD). Current gastroenterology reports. - 2014. - №7 (16). - p. 393.

23. Hensgens M.P.M. et al. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. The Journal of antimicrobial chemotherapy. - 2012. - №3 (67). - p. 742-8.

24. Huang H. et al. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China. Anaerobe. - 2014. (30). p. 65-69.

25. Johnson S. et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. The American Journal of Medicine. - 1990. - №2 (88). - p. 137-140.

26. Kim J. et al. Epidemiology and Clinical Characteristics of Clostridium difficile Infection in a Korean Tertiary Hospital. Journal of Korean Medical Science. - 2011. - №10 (26). - p. 1258.

27. Kim J.W. et al. Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea. World Journal of Gastroenterology. - 2010. - №28 (16). - p. 3573-7.

28. Kundrapu S. et al. A Randomized Trial of Soap and Water Hand Wash Versus Alcohol Hand Rub for Removal of Clostridium difficile Spores from Hands of Patients. Infection Control & Hospital Epidemiology. - 2014. - №2 (35). - p. 204-206.

29. Landellep et al. Contamination of Healthcare Workers’ Hands with Clostridium difficile Spores after Caring for Patients with difficile Infection. Infection Control & Hospital Epidemiology. - 2014. - №1 (35). -p. 10-15.

30. Larson H.E. et al. Undescribed toxin in pseudomembranous colitis. BMJ. - 1977. - № 6071 (1).

31. Lee H.C. et al. Clinical Outcomes in Hospitalized Patients with Clostridium difficile Infection by Age Group. The Korean Journal of Gastroenterology. - 2016. - №2 (67). - p. 81.

32. Levin J. et al. The effect of portable pulsed xenon ultraviolet light after terminal cleaning on hospital-associated Clostridium difficile infection in a community hospital. - 2013.

33. MacLaren R. et al. Histamine-2 Receptor Antagonists vs Proton Pump Inhibitors on Gastrointestinal Tract Hemorrhage and Infectious Complications in the Intensive Care Unit. JAMA Internal. Medicine. - 2014. - №4 (174). - p. 564.

34. McFarland L.V., Surawiczp M. Clostridium Difficile Associated Disease: Diagnosis and Treatment Oxford, UK: Wiley-Blackwell. - 2010. p. 335-354.

35. Pépin J. et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne. - 2004. - №5 (171). - p. 466-72.

36. Phatharacharukul P. et al. The Risks of Incident and Recurrent Clostridium difficile-Associated Diarrhea in Chronic Kidney Disease and End-Stage Kidney Disease Patients: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences. - 2015. - №10 (60). - p. 2913-2922.

37. Potter V.A., Aravinthan A. Identifying patients at risk of severe Clostridium difficile-associated disease. British Journal of Hospital Medicine (London, England: 2005). - 2012. - №5 (73). - p. 265-70.

38. Qu H.-Q., Jiang Z.-D. Clostridium difficile infection in diabetes. Diabetes research and clinical practice. - 2014. - №3 (105). p. 285-94.

39. Rodriguezp et al. Clostridium difficile infection in elderly nursing home residents. Anaerobe. 2014. (30). - p. 184-187.

40. Schneeweiss S. et al. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Alimentary Pharmacology & Therapeutics. - 2009. - №3 (30). - p. 253-264.

41. Skricka T. et al. Клостридиальный колит - важная проблема в хирургии. Колопроктология. -2014. - №4 (50). - p. 17-23.

42. Steindl G. et al. Effect of airborne hydrogen peroxide on spores of Clostridium difficile. Wiener klinische Wochenschrift. - 2015. - №11-12 (127). -p. 421-426.

43. Surawiczp.M. et al. Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections. The American Journal of Gastroenterology. - 2013. - №4 (108). - p. 478-498.

44. Vesoulis Z., Williams G., Matthews B. Pseudomembranous enteritis after proctocolectomy. Diseases of the Colon & Rectum. - 2000. - №4 (43). -p. 551-554.

45. Zhang T. et al. Clostridium Difficile Infection Worsen Outcome of Hospitalized Patients with Inflammatory Bowel Disease. Scientific reports. - 2016. (6). - p. 29791.